Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2018 Genitourinary Cancers Symposium /
Management of marker negative stage II testicular cancer

8th - 10th Feb 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 16.03.18
Views: 1129
Rating:

Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada

Dr Kollmannsberger speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about the management of marker negative stage II testicular cancer.

He then goes on to discuss treatment challenges in testicular cancer in general and highlights the need to improve the quality of care on a broad basics across the world. 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation